QVT score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy
Young Kwang Chae, Vamsidhar Velcheti, Kai Zhang, Amogh Hiremath et autres
BACKGROUND: Immune checkpoint inhibitors (ICIs) improve survival in advanced non-small cell lung cancer (NSCLC), yet current biomarkers such as programmed death-ligand 1 (PD-L1) expression and response criteria (Response Evaluation Criteria in Solid Tumors, RECIST, V.1.1) align poorly with long-term survival. Radiomics has …
us, ca (code pays fourni par la source)
3 citations
Journal for ImmunoTherapy of Cancer